A purple and pink letter v on a white background.
April 24, 2019

The Most Important Questions to Ask a Sales Rep

When it comes to making a new medical aesthetics device purchase, there is a lot of pressure on you as a buyer. Not only do you need to ensure you stick within a thoughtful budget that puts your clinic’s finances first, but you also need to feel confident that the device you purchase can bring in the kind of return on investment (ROI) your clinic needs. Investing in new technology can feel like an immense decision that requires a lot of thought and trust between buyer and seller. While there are many ways in which your purchase can go wrong, there is one major red flag many purchasers ignore that could lead to a major loss for your clinic, and leaving you with a device that really doesn’t suit your clinic’s unique needs or complement your current service offerings.

Anxiousness Is a Major Red Flag

It can be easy to get caught up in the details and become exasperated with choices when trying to find the perfect new device for your clinic. While anxiousness may seem like a natural reaction to a major purchase, it shouldn’t be your main emotion. In fact, fear and anxiety are one of the most common red flags aesthetics practices ignore, making this the biggest mistake clinics most often make when purchasing a new device.  

There shouldn’t be any uncertainty or fear with adding a new device to your services lineup. Companies that push you to accept a device that’s “good enough” are simply in it for the sale and don’t have your best interests in mind. Skip these offers and instead, seek out a device company that works to offer a solution that puts your practice’s unique clinical and financial needs first. You may even favor companies that are honest if they do not have a device that falls within those parameters but are upfront about it and offer an option that comes very close to meeting all your criteria with some added support—especially if they respect your need to take some time in making your decision.

Deadlines Don’t Exist

There should never be the pressure of an end-of-quarter deadline for any purchase. While every business has its quarterly sales goals, adding pressure to sign by a deadline or lose out on your agreed-upon terms is simply a tactic that sales representatives use to meet quotas and get commissions. As a buyer, your business’ best interests should come first. Making a purchase with any sense of buyer’s remorse creates a poor foundation for implementing a new device into your practice. Instead, ensure each purchase is surrounded by excitement and anticipation in providing your patients with the latest leading, in-demand services.

Don’t Ignore a Gut Instinct

All companies are looking to turn a profit—that’s the nature of business. However, a sign of a well-run business is one that seeks out a positive ongoing partnership with their customers rather than a simple sale. Do not ignore any feelings of anxiousness or lingering concerns; address them with the sales representative and ensure you feel good about what has been discussed before firming up any type of purchase.

The Bottom Line

Purchasing a new medical aesthetics device is an investment that should work in your clinic’s favor while offering safe and effective treatments for your patients. That being said, purchasing a product without doing your due diligence can put both your patients and your business at risk. Ensuring you have complete confidence in your purchase is one significant way to avoid making any poor purchases that may hurt your aesthetics business, but there are other common mistakes practices make that should also be avoided for a better ROI and increased confidence in your device choice.

Become a self-educated buyer by knowing which red flags to watch for and the right questions to ask to ensure you’re making an informed decision that will improve your clinic’s overall success with our new report, The Risky Business of Buying Technology: The Most Important Questions to Ask a Sales Rep. Download your full copy today using the link below.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.